Franzmann EJ - Search Results

1

CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression.

Perez A, Neskey DM, Wen J, Pereira L, Reategui EP, Goodwin WJ, Carraway KL, Franzmann EJ. Perez A, et al. Among authors: franzmann ej. Oral Oncol. 2013 Apr;49(4):306-13. doi: 10.1016/j.oraloncology.2012.11.009. Epub 2012 Dec 20. Oral Oncol. 2013. PMID: 23265944 Free PMC article.

2

A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression.

Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LY. Franzmann EJ, et al. Otolaryngol Head Neck Surg. 2001 Apr;124(4):426-32. doi: 10.1067/mhn.2001.114674. Otolaryngol Head Neck Surg. 2001. PMID: 11283501

3

Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.

Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB. Franzmann EJ, et al. Int J Cancer. 2003 Sep 1;106(3):438-45. doi: 10.1002/ijc.11252. Int J Cancer. 2003. PMID: 12845686 Free article.

4

Salivary soluble CD44: a potential molecular marker for head and neck cancer.

Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ. Franzmann EJ, et al. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):735-9. doi: 10.1158/1055-9965.EPI-04-0546. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767360

5

Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer.

Franzmann EJ, Lundy DS, Abitbol AA, Goodwin WJ. Franzmann EJ, et al. Head Neck. 2006 Aug;28(8):663-70. doi: 10.1002/hed.20392. Head Neck. 2006. PMID: 16783832

6

Characterization of CD44v3-containing isoforms in head and neck cancer.

Reategui EP, de Mayolo AA, Das PM, Astor FC, Singal R, Hamilton KL, Goodwin WJ, Carraway KL, Franzmann EJ. Reategui EP, et al. Among authors: franzmann ej. Cancer Biol Ther. 2006 Sep;5(9):1163-8. doi: 10.4161/cbt.5.9.3065. Epub 2006 Sep 11. Cancer Biol Ther. 2006. PMID: 16855392

7

Soluble CD44 is a potential marker for the early detection of head and neck cancer.

Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ. Franzmann EJ, et al. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1348-55. doi: 10.1158/1055-9965.EPI-06-0011. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17627000

8

Unequal burden of head and neck cancer in the United States.

Goodwin WJ, Thomas GR, Parker DF, Joseph D, Levis S, Franzmann E, Anello C, Hu JJ. Goodwin WJ, et al. Head Neck. 2008 Mar;30(3):358-71. doi: 10.1002/hed.20710. Head Neck. 2008. PMID: 17972309

9

Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.

Franzmann EJ, Reategui EP, Pereira LH, Pedroso F, Joseph D, Allen GO, Hamilton K, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB. Franzmann EJ, et al. Head Neck. 2012 May;34(5):687-95. doi: 10.1002/hed.21810. Epub 2011 Jul 11. Head Neck. 2012. PMID: 22294418 Free PMC article.

10

Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection.

Pereira LH, Adebisi IN, Perez A, Wiebel M, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB, Franzmann EJ. Pereira LH, et al. Among authors: franzmann ej. Cancer Biomark. 2011;10(5):241-9. doi: 10.3233/cbm-2012-0252. Cancer Biomark. 2011. PMID: 22699785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page